Melanomas

The risk for melanoma-related death increased among patients with T1 melanoma tumors thicker than 0.8 mm, according to a study.

Three women oncologist researchers at Dana Farber Cancer Institute have been named recipients of the Damon Runyon Cancer Research Foundation Clinical Investigator Award.

Adjuvant treatment with messenger RNA in combination with Keytruda produced meaningful improvement in patients with resected high-risk melanoma, according to findings from a phase 2b study.

Primary melanomas with incipient ulceration may be more aggressive than nonulcerated melanomas, thus warranting a higher-risk pathologic T stage, according to a study.

Specialty training in dermatopathology correlated with a greater tendency to diagnose low risk melanomas as more severe, according to a study.

The FDA announced several regulatory actions the past few weeks.

Cutaneous immune-related adverse events are associated with increased survival rates among immune checkpoint inhibitor recipients, particularly in patients with melanoma, according to a study.

Among patients with T1a cutaneous melanomas, younger age and tumors in the head/neck region were most likely to demonstrate sentinel lymph node positivity, according to a study.

Patients with second primary melanomas showed significant survival advantage and thinner lesions compared with those with single primary melanomas, according to a study published in the Journal of the American Academy of Dermatology.

Tissue-rearranging reconstruction is needed more in melanomas of the head and neck, which have high local recurrence rates, compared with keratinocyte carcinomas, according to a study.